Article info
PDFResearch Article
Genetically determined obesity in Prader-Willi syndrome: the ethics and legality of treatment.
Citation
Genetically determined obesity in Prader-Willi syndrome: the ethics and legality of treatment.
Publication history
- First published June 1, 1999.
Online issue publication
June 01, 1999
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- What is the value of growth hormone therapy in Prader Willi syndrome?
- Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region
- Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader–Willi syndrome
- Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome
- Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy
- Exclusion of maternal uniparental disomy of chromosome 14 in patients referred for Prader-Willi syndrome using a multiplex methylation polymerase chain reaction assay
- Relationship between clinical and genetic diagnosis of Prader-Willi syndrome
- Growth hormone therapy in the Prader-Willi syndrome
- Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study
- Three scenarios illustrating ethical concerns when considering bariatric surgery in obese adolescents with Prader-Willi syndrome